Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.447, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bisoprolol cost-effective addition in CHF in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Bisoprolol cost-effective addition in CHF in Sweden
Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. :
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :
Malaria IPTi with pyrimethamine/sulfadoxine "highly cost-effective"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. :
Genetic screening for HCM a "highly cost-effective" option
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. :